The Ivy Brain Tumor Center at Barrow Neurological Institute announced the treatment of their first patient in a Phase 0 clinical trial for newly diagnosed glioblastoma and recurrent glioblastoma. This trial is investigating Pamiparib’s effect on crossing …
March 11, 2021
OncoSynergy, Inc. launched the company’s First-in-Human Phase 1 clinical trial evaluating a treatment of recurrent glioblastoma. Today they announced the first patient has been treated in this trial using OS2966, a first-in-class immunotherapy, and the …
March 10, 2021
Written by: Courtney Benisch | Regional Relationship Coordinator for Head for the Cure and Brains for the Cure Ambassador The past year has been tough mentally, physically, and emotionally. In an all-consuming time where we are …
March 9, 2021
Written by Kim Asbury, Brains for the Cure Ambassador and Caregiver My sister, Lori Jo, and I have always had a very close relationship even before she was diagnosed with brain cancer. Considering she was …
March 3, 2021
Dr. John Boockvar, a Head for the Cure partner on our New York–area events and one of the subjects of the medical docu-drama Lenox Hill on Netflix, has recently begun the Phase 1 trial of …
March 2, 2021
Mitch’s wife, Allie, was diagnosed with a grade III anaplastic ependymoma brain tumor in 2016. He, along with Allie’s parents, fill the role of being her caregivers. As a caregiver, your focus is typically on …
February 22, 2021
In a global clinical trial, GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment), Henry Ford Cancer Institute is the first to activate two new treatments for glioblastoma. The GBM AGILE trial allows for global collaboration …
February 15, 2021
Brains for the Cure’s writers review several important developments in recent pediatric brain tumor research.
February 12, 2021
When treating a patient, no matter their diagnosis, a doctor learns about the patient, but also their family and friends. Dr. Nick Avgeropoulos wants to know the answers to many questions, so that he feels …
February 5, 2021
GammaTile is a radiation treatment that has been recently FDA-cleared and is specifically designed for use inside the brain to give patients immediate and targeted radiation after the tumor is removed during surgery.
February 3, 2021
